Hepatitis B is an infectious disease caused by the hepatitis B virus (“HBV”). Individuals who develop chronic HBV are at much greater risk for liver disease later on in their life. The greatest risk posed is potential cirrhosis of the liver and hepatocellular carcinoma. The U.S. is the largest individual market and is growing rapidly.
Chronic Hepatitis B
Hepion is dedicated to serving patients and healthcare professionals by developing clinically-differentiated therapeutic products that address high-need market segments. Hepion brings its financing, product development, and commercialization expertise to create long-term value for partners with unique clinical candidates.